HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis.

AbstractOBJECTIVE:
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that mainly targets joints. Monocytes and macrophages are critical in RA pathogenesis and contribute to inflammatory lesions. These extremely plastic cells respond to extracellular signals which cause epigenomic changes that define their pathogenic phenotype. Here, we interrogated how DNA methylation alterations in RA monocytes are determined by extracellular signals.
METHODS:
High-throughput DNA methylation analyses of patients with RA and controls and in vitro cytokine stimulation were used to investigate the underlying mechanisms behind DNA methylation alterations in RA as well as their relationship with clinical parameters, including RA disease activity.
RESULTS:
The DNA methylomes of peripheral blood monocytes displayed significant changes and increased variability in patients with RA with respect to healthy controls. Changes in the monocyte methylome correlate with DAS28, in which high-activity patients are divergent from healthy controls in contrast to remission patients whose methylome is virtually identical to healthy controls. Indeed, the notion of a changing monocyte methylome is supported after comparing the profiles of same individuals at different stages of activity. We show how these changes are mediated by an increase in disease activity-associated cytokines, such as tumour necrosis factor alpha and interferons, as they recapitulate the DNA methylation changes observed in patients in vitro.
CONCLUSION:
We demonstrate a direct link between RA disease activity and the monocyte methylome through the action of inflammation-associated cytokines. Finally, we have obtained a DNA methylation-based mathematical formula that predicts inflammation-mediated disease activity for RA and other chronic immune-mediated inflammatory diseases.
AuthorsJavier Rodríguez-Ubreva, Carlos de la Calle-Fabregat, Tianlu Li, Laura Ciudad, Maria L Ballestar, Francesc Català-Moll, Octavio Morante-Palacios, Antonio Garcia-Gomez, Raquel Celis, Frances Humby, Alessandra Nerviani, Javier Martin, Costantino Pitzalis, Juan D Cañete, Esteban Ballestar
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 78 Issue 11 Pg. 1505-1516 (11 2019) ISSN: 1468-2060 [Electronic] England
PMID31371305 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Chemical References
  • Biomarkers
  • Cytokines
  • Inflammation Mediators
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
Topics
  • Arthritis, Rheumatoid (blood, genetics)
  • Biomarkers (blood)
  • Cytokines (blood)
  • DNA Methylation (immunology)
  • Epigenome (immunology)
  • Humans
  • Inflammation Mediators (blood)
  • Leukocytes, Mononuclear (immunology)
  • Macrophages (immunology)
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: